Compile Data Set for Download or QSAR
Report error Found 31 Enz. Inhib. hit(s) with all data for entry = 50007737
TargetNeutrophil elastase(Human)
Glaxowellcome Medicines Research Centre

Curated by ChEMBL
LigandPNGBDBM50066999((S)-3,3-Diethyl-2-[4-(4-methyl-piperazine-1-carbon...)
Affinity DataIC50: 23nMAssay Description:The compound was tested for inhibition of human neutrophil elastase enzyme with a pre-incubation time of 0 min.More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetNeutrophil elastase(Human)
Glaxowellcome Medicines Research Centre

Curated by ChEMBL
LigandPNGBDBM50066999((S)-3,3-Diethyl-2-[4-(4-methyl-piperazine-1-carbon...)
Affinity DataIC50: 36nMAssay Description:The compound was tested for inhibition of human neutrophil elastase enzyme with a pre-incubation time of 40 min.More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetNeutrophil elastase(Human)
Glaxowellcome Medicines Research Centre

Curated by ChEMBL
LigandPNGBDBM50067002((3R,6aS)-3-Allyl-2-oxo-hexahydro-furo[3,2-b]pyrrol...)
Affinity DataIC50: 47nMAssay Description:The compound was tested for inhibition of human neutrophil elastase enzyme with a pre-incubation time of 40 min.More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetNeutrophil elastase(Human)
Glaxowellcome Medicines Research Centre

Curated by ChEMBL
LigandPNGBDBM50066997(CHEMBL2367632 | (3aS,6R)-6-Allyl-4-methanesulfonyl...)
Affinity DataIC50: 56nMAssay Description:The compound was tested for inhibition of human neutrophil elastase enzyme with a pre-incubation time of 40 min.More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetNeutrophil elastase(Human)
Glaxowellcome Medicines Research Centre

Curated by ChEMBL
LigandPNGBDBM50066998((3R,6aS)-3-Allyl-2-oxo-hexahydro-furo[3,2-b]pyrrol...)
Affinity DataIC50: 69nMAssay Description:The compound was tested for inhibition of human neutrophil elastase enzyme with a pre-incubation time of 15 min.More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetNeutrophil elastase(Human)
Glaxowellcome Medicines Research Centre

Curated by ChEMBL
LigandPNGBDBM50066996((3S,6aS)-3-Allyl-2-oxo-hexahydro-furo[3,2-b]pyrrol...)
Affinity DataIC50: 74nMAssay Description:The compound was tested for inhibition of human neutrophil elastase enzyme with a pre-incubation time of 40 min.More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetNeutrophil elastase(Human)
Glaxowellcome Medicines Research Centre

Curated by ChEMBL
LigandPNGBDBM50067000((3aS,6R)-6-Allyl-4-(naphthalene-1-sulfonyl)-5-oxo-...)
Affinity DataIC50: 88nMAssay Description:The compound was tested for inhibition of human neutrophil elastase enzyme with a pre-incubation time of 40 min.More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetNeutrophil elastase(Human)
Glaxowellcome Medicines Research Centre

Curated by ChEMBL
LigandPNGBDBM50067002((3R,6aS)-3-Allyl-2-oxo-hexahydro-furo[3,2-b]pyrrol...)
Affinity DataIC50: 336nMAssay Description:The compound was tested for inhibition of human neutrophil elastase enzyme with a pre-incubation time of 0 min.More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetChymotrypsinogen A(Bovine)
Glaxowellcome Medicines Research Centre

Curated by ChEMBL
LigandPNGBDBM50066999((S)-3,3-Diethyl-2-[4-(4-methyl-piperazine-1-carbon...)
Affinity DataIC50: 980nMAssay Description:The compound was tested for inhibition of Chymotrypsinogen with a pre-incubation time of 15 minMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCathepsin G(Human)
Glaxowellcome Medicines Research Centre

Curated by ChEMBL
LigandPNGBDBM50066998((3R,6aS)-3-Allyl-2-oxo-hexahydro-furo[3,2-b]pyrrol...)
Affinity DataIC50: 3.60E+3nMAssay Description:The compound was tested for inhibition of cathepsin G with a pre-incubation time of 15 minMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetChymotrypsinogen A(Bovine)
Glaxowellcome Medicines Research Centre

Curated by ChEMBL
LigandPNGBDBM50066998((3R,6aS)-3-Allyl-2-oxo-hexahydro-furo[3,2-b]pyrrol...)
Affinity DataIC50: 4.00E+3nMAssay Description:The compound was tested for inhibition of Chymotrypsinogen with a pre-incubation time of 15 minMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetChymotrypsinogen A(Bovine)
Glaxowellcome Medicines Research Centre

Curated by ChEMBL
LigandPNGBDBM50066996((3S,6aS)-3-Allyl-2-oxo-hexahydro-furo[3,2-b]pyrrol...)
Affinity DataIC50: 4.86E+3nMAssay Description:The compound was tested for inhibition of Chymotrypsinogen with a pre-incubation time of 15 minMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetChymotrypsinogen A(Bovine)
Glaxowellcome Medicines Research Centre

Curated by ChEMBL
LigandPNGBDBM50067000((3aS,6R)-6-Allyl-4-(naphthalene-1-sulfonyl)-5-oxo-...)
Affinity DataIC50: 1.15E+4nMAssay Description:The compound was tested for inhibition of Chymotrypsinogen with a pre-incubation time of 15 minMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetNeutrophil elastase(Human)
Glaxowellcome Medicines Research Centre

Curated by ChEMBL
LigandPNGBDBM50066996((3S,6aS)-3-Allyl-2-oxo-hexahydro-furo[3,2-b]pyrrol...)
Affinity DataIC50: 1.28E+4nMAssay Description:The compound was tested for inhibition of human neutrophil elastase enzyme with a pre-incubation time of 0 min.More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetChymotrypsinogen A(Bovine)
Glaxowellcome Medicines Research Centre

Curated by ChEMBL
LigandPNGBDBM50067002((3R,6aS)-3-Allyl-2-oxo-hexahydro-furo[3,2-b]pyrrol...)
Affinity DataIC50: 1.59E+4nMAssay Description:The compound was tested for inhibition of Chymotrypsinogen with a pre-incubation time of 15 minMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetChymotrypsinogen A(Bovine)
Glaxowellcome Medicines Research Centre

Curated by ChEMBL
LigandPNGBDBM50066997(CHEMBL2367632 | (3aS,6R)-6-Allyl-4-methanesulfonyl...)
Affinity DataIC50: 4.06E+4nMAssay Description:The compound was tested for inhibition of Chymotrypsinogen with a pre-incubation time of 15 minMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetProthrombin(Human)
Glaxowellcome Medicines Research Centre

Curated by ChEMBL
LigandPNGBDBM50066997(CHEMBL2367632 | (3aS,6R)-6-Allyl-4-methanesulfonyl...)
Affinity DataIC50: 4.06E+4nMAssay Description:The compound was tested for inhibition of thrombin with a pre-incubation time of 15 min.More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetNeutrophil elastase(Human)
Glaxowellcome Medicines Research Centre

Curated by ChEMBL
LigandPNGBDBM50066997(CHEMBL2367632 | (3aS,6R)-6-Allyl-4-methanesulfonyl...)
Affinity DataIC50: 4.06E+4nMAssay Description:The compound was tested for inhibition of human neutrophil elastase enzyme with a pre-incubation time of 40 min.More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCathepsin G(Human)
Glaxowellcome Medicines Research Centre

Curated by ChEMBL
LigandPNGBDBM50066997(CHEMBL2367632 | (3aS,6R)-6-Allyl-4-methanesulfonyl...)
Affinity DataIC50: 4.06E+4nMAssay Description:The compound was tested for inhibition of cathepsin G with a pre-incubation time of 15 minMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetProthrombin(Human)
Glaxowellcome Medicines Research Centre

Curated by ChEMBL
LigandPNGBDBM50066996((3S,6aS)-3-Allyl-2-oxo-hexahydro-furo[3,2-b]pyrrol...)
Affinity DataIC50: 4.46E+4nMAssay Description:The compound was tested for inhibition of thrombin with a pre-incubation time of 15 minMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetProthrombin(Human)
Glaxowellcome Medicines Research Centre

Curated by ChEMBL
LigandPNGBDBM50067002((3R,6aS)-3-Allyl-2-oxo-hexahydro-furo[3,2-b]pyrrol...)
Affinity DataIC50: 4.90E+4nMAssay Description:The compound was tested for inhibition of thrombin with a pre-incubation time of 15 minMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCathepsin G(Human)
Glaxowellcome Medicines Research Centre

Curated by ChEMBL
LigandPNGBDBM50066996((3S,6aS)-3-Allyl-2-oxo-hexahydro-furo[3,2-b]pyrrol...)
Affinity DataIC50: 6.70E+4nMAssay Description:The compound was tested for inhibition of cathepsin G with a pre-incubation time of 15 minMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetProthrombin(Human)
Glaxowellcome Medicines Research Centre

Curated by ChEMBL
LigandPNGBDBM50066999((S)-3,3-Diethyl-2-[4-(4-methyl-piperazine-1-carbon...)
Affinity DataIC50: 7.88E+4nMAssay Description:The compound was tested for inhibition of thrombin with a preincubation time of 15 minMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetNeutrophil elastase(Human)
Glaxowellcome Medicines Research Centre

Curated by ChEMBL
LigandPNGBDBM50067000((3aS,6R)-6-Allyl-4-(naphthalene-1-sulfonyl)-5-oxo-...)
Affinity DataIC50: 1.00E+5nMAssay Description:The compound was tested for inhibition of human neutrophil elastase enzyme with a pre-incubation time of 0 min.More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetChymotrypsinogen A(Bovine)
Glaxowellcome Medicines Research Centre

Curated by ChEMBL
LigandPNGBDBM50067001(CHEMBL2367635 | (3aS,6R)-6-Allyl-5-oxo-hexahydro-p...)
Affinity DataIC50: 1.00E+5nMAssay Description:The compound was tested for inhibition of Chymotrypsinogen with a pre-incubation time of 15 min.More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetProthrombin(Human)
Glaxowellcome Medicines Research Centre

Curated by ChEMBL
LigandPNGBDBM50067001(CHEMBL2367635 | (3aS,6R)-6-Allyl-5-oxo-hexahydro-p...)
Affinity DataIC50: 1.00E+5nMAssay Description:The compound was tested for inhibition of thrombin with a pre-incubation time of 15 min.More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCathepsin G(Human)
Glaxowellcome Medicines Research Centre

Curated by ChEMBL
LigandPNGBDBM50067002((3R,6aS)-3-Allyl-2-oxo-hexahydro-furo[3,2-b]pyrrol...)
Affinity DataIC50: 1.00E+5nMAssay Description:The compound was tested for inhibition of cathepsin G with a pre-incubation time of 15 min.More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetNeutrophil elastase(Human)
Glaxowellcome Medicines Research Centre

Curated by ChEMBL
LigandPNGBDBM50067001(CHEMBL2367635 | (3aS,6R)-6-Allyl-5-oxo-hexahydro-p...)
Affinity DataIC50: 1.00E+5nMAssay Description:The compound was tested for inhibition of human neutrophil elastase enzyme with a pre-incubation time of 40 min.More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetProthrombin(Human)
Glaxowellcome Medicines Research Centre

Curated by ChEMBL
LigandPNGBDBM50067000((3aS,6R)-6-Allyl-4-(naphthalene-1-sulfonyl)-5-oxo-...)
Affinity DataIC50: 1.00E+5nMAssay Description:The compound was tested for inhibition of thrombin with a pre-incubation time of 15 min.More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetProthrombin(Human)
Glaxowellcome Medicines Research Centre

Curated by ChEMBL
LigandPNGBDBM50066998((3R,6aS)-3-Allyl-2-oxo-hexahydro-furo[3,2-b]pyrrol...)
Affinity DataIC50: 2.00E+5nMAssay Description:The compound was tested for inhibition of thrombin with a pre-incubation time of 15 min.More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetNeutrophil elastase(Human)
Glaxowellcome Medicines Research Centre

Curated by ChEMBL
LigandPNGBDBM50067001(CHEMBL2367635 | (3aS,6R)-6-Allyl-5-oxo-hexahydro-p...)
Affinity DataIC50: 5.00E+5nMAssay Description:The compound was tested for inhibition of human neutrophil elastase enzyme with a pre-incubation time of 40 min.More data for this Ligand-Target Pair
In DepthDetails Article
PubMed